<DOC>
	<DOCNO>NCT01148862</DOCNO>
	<brief_summary>The purpose study assess efficacy Low Glucose Suspend ( LGS ) feature reduce hypoglycemia MiniMed Paradigm® X54 System hypoglycemic induction exercise . The study consist total 50 subject , age 16 60 year Type 1 Diabetes Mellitus .</brief_summary>
	<brief_title>Assess Efficacy Low Glucose Suspend ( LGS ) Feature MiniMed Paradigm® X54 System</brief_title>
	<detailed_description>50 subject previously diagnose Type 1 Diabetes Mellitus study . The subject population include follow subset : 4 pediatric subject age 16 -17 year , 4 young adult subject age 18-21 year , 42 adult subject age 22-60 year time enrollment . Results subject analyze .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>Subject age 16 60 year old A clinical diagnosis Type 1 Diabetes Mellitus , determine Investigator , minimum 12 month duration Subject Medtronic insulin pump least 3 month , include limited sensor augment insulin pump therapy Subject A1C value ≥ 7.0 % ≤ 10.0 % time enrollment ; measure screen visit Subject must document stress treadmill test within last three year enrollment subject diabetes &gt; 20 year Subject willing follow protocol procedure study . Systolic blood pressure screen visit &gt; 140 Millimeters Mercury Diastolic blood pressure screen visit &gt; 90 Millimeters Mercury Subject history hypoglycemic seizure hypoglycemic coma within last two year Subject unable tolerate tape adhesive area sensor placement ; Subject active adverse skin condition area sensor placement ( i.e . psoriasis , rash , staphylococcus infection ) resolve time enrollment Subject pregnant plan become pregnant course study Subject history myocardial infarction , unstable angina , coronary artery bypass surgery , coronary artery stenting , transient ischemic attack , cerebrovascular accident , angina , congestive heart failure , ventricular rhythm disturbance thromboembolic disease Subject active Graves disease Subject renal impairment creatinine normal reference range ( laboratory clinical site utilizing ) , demonstrate screen laboratory value Subject outside normal reference range ( laboratory clinical site utilize ) hematocrit , demonstrate screen laboratory value Subject outside normal reference range ( laboratory clinical site utilize ) potassium , demonstrate screen laboratory value Subject outside normal reference range ( laboratory clinical site utilize ) ThyroidStimulating Hormone ( TSH ) , demonstrate screen laboratory value Subject outside normal reference range ( laboratory clinical site utilize ) free Thyroxine ( T4 ) , demonstrate screen laboratory value Subject history smoking &gt; 5 year Electrocardiogram finding observe screen visit , deem investigator represent active ischemia condition would compromise subject safety The stress treadmill ( subject meet inclusion criterion # 7 ) result deem investigator represent active ischemia condition would compromise subject safety Subject currently participate investigational study ( drug device ) Subject currently beta blocker medication Subject take oral injectable steroid within last 30 day Subject deem Investigator unwilling unable follow protocol Subject history diagnose medical eat disorder Subject history know illicit drug abuse Subject history know abuse prescription medication Subject history visual impairment would allow subject participate study perform study procedure safely per investigator discretion Subject history current alcohol abuse Any condition include abnormality find screen test opinion Investigator , may preclude him/her participating study</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>ASPIRE ( Automation Simulate Pancreatic Insulin Response )</keyword>
	<keyword>X54</keyword>
	<keyword>Medtronic Diabetes</keyword>
	<keyword>Diabetes Mellitus</keyword>
	<keyword>Type 1</keyword>
</DOC>